Study of the Pharmacokinetics of Mycophenolate Mofetil in Patients Who Have Undergone Orthotopic Liver Transplantation
NCT00007059 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2005-06-24
Summary
OBJECTIVES: I. Determine the effects of bile externalization and antibiotic gut sterilization on the pharmacokinetics of mycophenolate mofetil in patients who have undergone orthotopic liver transplantation.
II. Correlate serum concentrations of mycophenolic acid with inosine monophosphate dehydrogenase activity in these patients.
Conditions
Interventions
- DRUG
-
mycophenolate mofetil
Sponsors & Collaborators
-
University of North Carolina
collaborator OTHER -
National Center for Research Resources (NCRR)
lead NIH
Principal Investigators
-
Robert E. Dupuis · University of North Carolina
Study Design
- Purpose
- TREATMENT
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1998-06-30
Countries
- United States
Study Locations
More Related Trials
-
Measurement of Gastrointestinal (GI) and Health-related Quality of Life (HRQL) Outcomes in Liver Transplant Recipients
NCT00405652 ·Status: COMPLETED ·Phase: PHASE3
-
The Study to Evaluate Efficacy and Safety of MY-REPT Capsule in Primary, Liver Transplantation Recipients (MYLT1)
NCT01766518 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study of CellCept (Mycophenolate Mofetil) in Combination Therapy in Liver Transplant Patients.
NCT00545402 ·Status: COMPLETED ·Phase: PHASE4
-
Safety, Tolerability and Pharmacokinetics of Oral CellCept (Mycophenolate Mofetil) in Pediatric Liver Transplant Recipients on Concomitant Treatment With Cyclosporine and Corticosteroids
NCT02630563 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of CellCept (Mycophenolate Mofetil) Combined With Calcineurin Inhibitors in Liver Transplant Patients.
NCT00717314 ·Status: COMPLETED ·Phase: PHASE4
-
Long-term Benefit of MPA in Liver Transplantation
NCT05707520 ·Status: UNKNOWN
-
Clinical Study to Evaluate the Tolerability, Safety and Efficacy of Enteric-coated Mycophenolate Sodium After Equimolar Conversion From Mycophenolate Mofetil (MMF) in Patients With Renal Transplant
NCT00171379 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetics and Pharmacodynamics of MPA in Stable Renal Transplant Patients
NCT00780429 ·Status: UNKNOWN
-
Mycophenolate Mofetil Maintenance Therapy for Liver Transplantation
NCT00849238 ·Status: WITHDRAWN ·Phase: NA
-
Pharmacokinetics of Mmf and Valganciclovir
NCT00189150 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Therapeutic Monitoring of Mycophenolate Mofetil (MMF/CellCept) After Kidney Transplantation
NCT00087581 ·Status: COMPLETED ·Phase: PHASE4
-
Mycophenolate Mofetil (MMF): A Long-Term Data Evaluation
NCT00203671 ·Status: COMPLETED
-
A Prospective Study on the Tolerability and Efficacy of the de Novo Use of Myfortic in Liver Transplant Recipients
NCT00336817 ·Status: COMPLETED ·Phase: NA
-
A Study of Mycophenolate Mofetil and Cyclosporin, Without Concomitant Corticosteroids, After a First Renal Transplant
NCT00200551 ·Status: COMPLETED ·Phase: PHASE4
-
Measurement of Patient Reported Outcomes in Korean Renal Transplant Patients With and Without Gastrointestinal (GI) Symptoms
NCT00529269 ·Status: COMPLETED ·Phase: PHASE4
-
Cefepime Pharmacokinetics in Liver Transplant Recipients in an Intensive Care Unit
NCT00177931 ·Status: COMPLETED
-
A Study of CellCept (Mycophenolate Mofetil) in Combination Therapy in Heart Transplant Patients.
NCT02091414 ·Status: COMPLETED ·Phase: PHASE3
-
Standard Therapy or Individualized Immunosuppression For Lowering Adverse Event Risk
NCT04473924 ·Status: WITHDRAWN ·Phase: PHASE2
-
Concentration Controlled Versus Fixed Dose of MMF in Kidney Transplant Recipients
NCT00199667 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety of Cyclosporine Microemulsion Given Once a Day in Adult Stable Liver Transplant Recipients
NCT00171509 ·Status: COMPLETED ·Phase: PHASE4
-
Myfortic Conversion Trial in OLT Recipients With GI Intolerance
NCT00619216 ·Status: COMPLETED
-
Enteric-Coated Mycophenolate Sodium on Quality of Life in Patients With Gastrointestinal Symptoms Related to Mycophenolate Mofetil Therapy After Kidney Transplantation
NCT00239005 ·Status: COMPLETED ·Phase: PHASE4
-
A Pharmacokinetic Study of CellCept (Mycophenolate Mofetil) Versus Mycophenolate Sodium in Kidney Transplant Patients
NCT01033864 ·Status: COMPLETED ·Phase: PHASE4
-
Single Center Pilot Study of Corticosteroid Discontinuation in Liver Transplant Recipients
NCT00374231 ·Status: COMPLETED ·Phase: PHASE4
-
A Study Designed to Compare the Tolerability of an Increased Dose of Enteric-coated Mycophenolate Acid (MPA) in Renal Transplant Patients Whose Dose of Mycophenolate Mofetil (MMF) Was Reduced Due to Gastrointestinal Symptoms
NCT00658333 ·Status: TERMINATED ·Phase: PHASE4